Fc-Silent Anti-TIGIT Antibodies Potentiate Antitumor Immunity without Depleting Regulatory T Cells.
Dana PiovesanAmber E de GrootSoonweng ChoAmy E AndersonRebecca D RayAmita PatnaikPaul G FosterCasey G MitchellAlejandra Y Lopez EspinozaWandi S ZhuCarlo E StagnaroHema SinghXiaoning ZhaoLisa SeitzNigel P C WalkerMatthew J WaltersKelsey E SivickPublished in: Cancer research (2024)
Fcs-silent anti-TIGIT antibodies enhance the activation of tumor-specific pre-exhausted T cells and promote antitumor efficacy without depleting T regulatory cells.